Literature DB >> 25451224

miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3.

Fengzhen Huang1, Li Zhang2, Zhe Long2, Zhao Chen2, Xuan Hou2, Chunrong Wang2, Huirong Peng2, Junling Wang2, Jiada Li3, Ranhui Duan3, Kun Xia3, De-Maw Chuang4, Beisha Tang5, Hong Jiang6.   

Abstract

MicroRNAs (miRNAs) have been reported to play significant roles in the pathogenesis of various polyQ diseases. This study aims to investigate the regulation of ATXN3 gene expression by miRNA. We found that miR-25 reduced both wild-type and polyQ-expanded mutant ataxin-3 protein levels by interacting with the 3'UTR of ATXN3 mRNA. miR-25 also increased cell viability, decreased early apoptosis, and downregulated the accumulation of mutant ataxin-3 protein aggregates in SCA3/MJD cells. These novel results shed light on the potential role of miR-25 in the pathogenesis of SCA3/MJD, and provide a possible therapeutic intervention for this disorder.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATXN3; Cytotoxicity; Gene expression regulation; Neuronal intranuclear inclusion; Spinocerebellar ataxia type 3/Machado–Joseph disease; miR-25

Mesh:

Substances:

Year:  2014        PMID: 25451224      PMCID: PMC6370487          DOI: 10.1016/j.febslet.2014.11.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

Review 1.  Expanding our understanding of polyglutamine diseases through mouse models.

Authors:  X Lin; C J Cummings; H Y Zoghbi
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  The Elegance of the MicroRNAs: A Neuronal Perspective.

Authors:  Kenneth S Kosik; Anna M Krichevsky
Journal:  Neuron       Date:  2005-09-15       Impact factor: 17.173

Review 4.  The neuronal microRNA system.

Authors:  Kenneth S Kosik
Journal:  Nat Rev Neurosci       Date:  2006-12       Impact factor: 34.870

5.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration.

Authors:  Julide Bilen; Nan Liu; Barrington G Burnett; Randall N Pittman; Nancy M Bonini
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

6.  Extended polyglutamine selectively interacts with caspase-8 and -10 in nuclear aggregates.

Authors:  M U; T Miyashita; Y Ohtsuka; Y Okamura-Oho; Y Shikama; M Yamada
Journal:  Cell Death Differ       Date:  2001-04       Impact factor: 15.828

7.  Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.

Authors:  Sarah J Shoesmith Berke; Francisca A Flores Schmied; Ewout R Brunt; Lisa M Ellerby; Henry L Paulson
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

8.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.

Authors:  Sébastien S Hébert; Katrien Horré; Laura Nicolaï; Aikaterini S Papadopoulou; Wim Mandemakers; Asli N Silahtaroglu; Sakari Kauppinen; André Delacourte; Bart De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

9.  A toxic monomeric conformer of the polyglutamine protein.

Authors:  Yoshitaka Nagai; Takashi Inui; H Akiko Popiel; Nobuhiro Fujikake; Kazuhiro Hasegawa; Yoshihiro Urade; Yuji Goto; Hironobu Naiki; Tatsushi Toda
Journal:  Nat Struct Mol Biol       Date:  2007-03-18       Impact factor: 15.369

10.  The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils.

Authors:  Donatella Bulone; Laura Masino; David J Thomas; Pier Luigi San Biagio; Annalisa Pastore
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

View more
  15 in total

1.  Cardiac contractility modulation improves left ventricular systolic function partially via miR-25 mediated SERCA2A expression in rabbit trans aortic constriction heart failure model.

Authors:  Hongyun Chen; Shuang Liu; Cuiting Zhao; Zhihong Zong; Chunyan Ma; Guoxian Qi
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.

Authors:  Vitor Carmona; Janete Cunha-Santos; Isabel Onofre; Ana Teresa Simões; Udaya Vijayakumar; Beverly L Davidson; Luís Pereira de Almeida
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

3.  Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7.

Authors:  Verónica M Borgonio-Cuadra; Claudia Valdez-Vargas; Sandra Romero-Córdoba; Alfredo Hidalgo-Miranda; Yessica Tapia-Guerrero; César M Cerecedo-Zapata; Oscar Hernández-Hernández; Bulmaro Cisneros; Jonathan J Magaña
Journal:  Mol Neurobiol       Date:  2019-02-05       Impact factor: 5.590

4.  Genetic Variation in ATXN3 (Ataxin-3) 3'UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3.

Authors:  Ana Rosa Vieira Melo; Mafalda Raposo; Marta Ventura; Sandra Martins; Sara Pavão; Isabel Alonso; Conceição Bettencourt; Manuela Lima
Journal:  Cerebellum       Date:  2022-01-16       Impact factor: 3.847

5.  Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Authors:  Mercedes Prudencio; Hector Garcia-Moreno; Karen R Jansen-West; Rana Hanna Al-Shaikh; Tania F Gendron; Michael G Heckman; Matthew R Spiegel; Yari Carlomagno; Lillian M Daughrity; Yuping Song; Judith A Dunmore; Natalie Byron; Björn Oskarsson; Katharine A Nicholson; Nathan P Staff; Sorina Gorcenco; Andreas Puschmann; João Lemos; Cristina Januário; Mark S LeDoux; Joseph H Friedman; James Polke; Robin Labrum; Vikram Shakkottai; Hayley S McLoughlin; Henry L Paulson; Takuya Konno; Osamu Onodera; Takeshi Ikeuchi; Mari Tada; Akiyoshi Kakita; John D Fryer; Christin Karremo; Inês Gomes; John N Caviness; Mark R Pittelkow; Jan Aasly; Ronald F Pfeiffer; Venka Veerappan; Eric R Eggenberger; William D Freeman; Josephine F Huang; Ryan J Uitti; Klaas J Wierenga; Iris V Marin Collazo; Philip W Tipton; Jay A van Gerpen; Marka van Blitterswijk; Guojun Bu; Zbigniew K Wszolek; Paola Giunti; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

6.  MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy.

Authors:  Naemeh Pourshafie; Philip R Lee; Ke-Lian Chen; George G Harmison; Laura C Bott; Masahisa Katsuno; Gen Sobue; Barrington G Burnett; Kenneth H Fischbeck; Carlo Rinaldi
Journal:  Mol Ther       Date:  2016-01-12       Impact factor: 11.454

7.  miRNA profiling in autism spectrum disorder in China.

Authors:  Fengzhen Huang; Tieqiao Zhou; Xiaoxi Yao; Jiping Yi; Fei Zhou; Zhe Long; Xuan Hou; Chunrong Wang; Zhao Chen; Hong Jiang
Journal:  Genom Data       Date:  2015-08-12

8.  Toward Understanding Non-coding RNA Roles in Intracranial Aneurysms and Subarachnoid Hemorrhage.

Authors:  Fengzhen Huang; Jiping Yi; Tieqiao Zhou; Xiaoxiang Gong; Hong Jiang; Xiaoxi Yao
Journal:  Transl Neurosci       Date:  2017-05-31       Impact factor: 1.757

Review 9.  A myriad of roles of miR-25 in health and disease.

Authors:  Márta Sárközy; Zsuzsanna Kahán; Tamás Csont
Journal:  Oncotarget       Date:  2018-04-20

Review 10.  Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.

Authors:  Toshihide Takeuchi; Yoshitaka Nagai
Journal:  Brain Sci       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.